CHI3L1 and Mental deterioration: Previous studies have shown that Aβ42, tau, YKL-40 (an astrocyte marker), and the ratios tau/Aβ42 and YKL-40/Aβ42 can predict subsequent cognitive decline in non-demented cohorts [7], [15], [87].